ArticleBreast cancer research : BCR2022

Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling.

Bénédicte Rousseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.